Glioma brain tumors are diffuse, so doctors usually cannot excise all of the cancer during surgery. Instead, they remove as much of the tumor as possible and then analyze the brain’s tissue post-operation. Researchers at Purdue have developed a new method in which mass spectrometry could be used during surgery to evaluate tissue. This information could help guide the surgical team’s decisions, increasing the amount of cancerous tissue they are able to remove and improving the patient’s outcomes.
How do dedicated Boilermakers overcome obstacles? Reagan Fahey (BS biology ’25) credits her Purdue experience and personal support system for helping her rally after she had to pause her medical school plans. Hear more in the new episode of “Relentless.”
